Proceedings for Annual Meeting of The Japanese Pharmacological Society
Online ISSN : 2435-4953
WCP2018 (The 18th World Congress of Basic and Clinical Pharmacology)
Session ID : WCP2018_PO2-4-16
Conference information

Poster session
Roles of brain nitric oxide in micturition of rats
Hideaki OnoTakahiro ShimizuShogo ShimizuYouichirou HigashiSuo ZouMasaki YamamotoTakaaki AratakeTomoya HamadaYoshiki NagaoMotoaki Saito
Author information
CONFERENCE PROCEEDINGS OPEN ACCESS

Details
Abstract

Background: Peripheral nitric oxide (NO) has a local inhibitory effect on urination, while, in the central nervous system, NO seems to have both inhibitory and facilitatory effects. We previously reported that SIN-1 (NO donor) centrally activated the sympatho-adrenomedullary (SA) system in rats. In this study, we investigated effects of centrally administered SIN-1 on micturition and their dependence on the SA system in rats.

Methods: Urethane-anesthetized (0.8 g/kg, ip) male Wistar rats (300-400 g) were used. (1) Catheters were inserted into the bladder and the femoral artery in order to measure intravesical pressure and to collect blood samples, respectively. SIN-1 (100 or 250 µg/rat) or vehicle was intracerebroventricularly (icv) administered. One hour before the administration, continuous intravesical instillation of sterile saline (12 ml/h) and measurement of intravesical pressure were started. Plasma noradrenaline and adrenaline levels were measured at 5 min after the administration. In some experiments, carboxy-PTIO (NO scavenger, 750 µg/rat, icv) was pretreated 30 min before SIN-1 administration (250 µg/rat, icv). (2) Single cystometry was performed in rats inserted a catheter into the bladder. Saline instillation (12 ml/h) was continued until the peak of a voiding bladder contraction; then the instillation was stopped and the saline voided from the bladder was collected and measured (single-voided volume, Vv). The bladder was then emptied to measure residual volume (post-voiding residual urine volume, Rv). This procedure was performed 4-5 times before SIN-1 administration (250 µg/rat, icv), and performed from 0 to 60 min after the administration. After experiments, bladder capacity (BC = Vv + Rv) and voiding efficiency (VE = Vv/BC) were calculated.

Results: (1) SIN-1 dose-dependently reduced intercontraction intervals (ICI) and elevated plasma adrenaline without altering maximal voiding pressure or plasma noradrenaline. An insufficient dose of SIN-1 (100 µg/rat) for elevating plasma adrenaline could induce ICI reduction. Carboxy-PTIO attenuated these SIN-1-induced responses. (2) SIN-1 reduced Vv and BC without altering Rv or VE.

Conclusions: NO centrally induces frequent urination shown by reduced ICI, Vv and BC, independent of the central SA outflow. Thus, the brain nitrergic pathway that can directly regulate micturition might be a potential therapeutic target for bladder dysfunction.

Content from these authors
© 2018 The Authors(s)
Previous article Next article
feedback
Top